Onconic Therapeutics Inc. (KOSDAQ:476060)
17,280
-1,800 (-9.43%)
At close: Dec 5, 2025
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 768.78 billion as of December 5, 2025.
Market Cap
768.78B
Enterprise Value
715.37B
Revenue
46.65B
Ranking
n/a
PE Ratio
45.89
Stock Price
17,280.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 768.78B, an increase of 311.32%. That is a compound annual growth rate of 335.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 768.78B | 335.48% |
| Dec 30, 2024 | 176.54B | -5.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.57T |
| Celltrion | 39.95T |
| ALTEOGEN | 27.76T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.61T |
| Yuhan | 8,911.91B |
| LigaChem Biosciences | 6,906.05B |
| Peptron | 6,668.76B |